Trivitron Healthcare in association with NeoGen Labs hosted the 2017 Newborn Screening Symposium on October 30, 2017 in Bangalore. Newborn Screening (NBS) is a test performed on babies, normally 24 to 72 hours after birth, to identify "Inborn Errors of Metabolism", or IEMs, and to treat them if they are identified for before they are adversely impacted. Trivitron has introduced state of the art technology in India to support NBS to improve neonatal care and ensure babies start their life healthy.

Visit Site